Attenuating Tumour Angiogenesis: A Preventive Role of Metformin against Breast Cancer
Metformin is one of the most widely prescribed antidiabetics for type 2 diabetes. A critical role of metformin against tumorigenesis has recently been implicated, although several studies also reported the lack of anticancer property of the antidiabetics. Given the controversies regarding the potent...
Main Authors: | Shan Gao, Jingcheng Jiang, Pan Li, Huijuan Song, Weiwei Wang, Chen Li, Deling Kong |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2015/592523 |
Similar Items
-
Ganoderma triterpenoids attenuate tumour angiogenesis in lung cancer tumour-bearing nude mice
by: Wei Liu, et al.
Published: (2020-01-01) -
Metformin: The next angiogenesis panacea?
by: Yu Ren, et al.
Published: (2021-03-01) -
Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo.
by: Jing Han, et al.
Published: (2018-01-01) -
Preventative metformin treatment increases myeloma tumour burden and bone disease in vivo
by: Beatriz Gamez, et al.
Published: (2020-10-01) -
Metformin as an energy restriction mimetic agent for breast cancer prevention
by: Zongjian Zhu, et al.
Published: (2011-01-01)